fda import alert 66-80 glp-1 green list apis creates "green list" to block unsafe imports FDA warns against compounded GLP-1

[DOI] [PMC free article] [PubMed] [Google Scholar] 140.Oprea A.D., Umpierrez G.E., Sweitzer B., Hepner D.L

The risk of urinary tract infections increased in patients who were 75 years of age and older to 10.5%, 15.7%, and 15.1% in patients randomized to placebo, JARDIANCE 10 mg, and JARDIANCE 25 mg, respectively [see Warnings and Precautions (5.2) and Adverse Reactions (6.1)]

To connect the psychological and behavioral mechanisms described earlier with their practical relevance for clinical management, Table 1 summarizes how GLP-1 RArelated changes could be leveraged during active treatment and where vulnerabilities may emerge after discontinuation

Retrieved from Carnival Cruise Line